Penumbra price target raised to $337 from $320 at Wells Fargo

Wells Fargo analyst Larry Biegelsen raised the firm’s price target on Penumbra to $337 from $320 and keeps an Overweight rating on the shares. The firm notes that Penumbra’s Q2 sales beat was driven by Neuro, and raised 2023 sales guidance largely reflects the beat.